Professor David Price
Chair of Primary Care Respiratory Med
- 51cg
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 23 of 39 Results 551 to 575 of 964
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
Allergy, Asthma & Immunology Research, vol. 9, no. 2, pp. 116-125Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Urinary prostanoids in preschool wheeze
European Respiratory Journal, vol. 49, no. 2, 1601390Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles
npj Primary Care Respiratory Medicine, vol. 27, 16089Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Development and Validation of an Attitudinal-Profiling Tool for Patients With Asthma
Allergy, Asthma & Immunology Research, vol. 9, no. 1, pp. 43-51Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
The Journal of Allergy and Clinical Immunology: In Practice, vol. 5, no. 1, pp. 99-106.e3Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA
Journal of Nutrition, Health & Aging, vol. 21, no. 1, pp. 92-104Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
International journal of chronic obstructive pulmonary disease , vol. 12, pp. 141—168Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
npj Primary Care Respiratory Medicine, vol. 27, 17Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
International journal of chronic obstructive pulmonary disease , vol. 12, pp. 59-71Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Use of electronic medical records and biomarkers to manage risk and resource efficiencies
European Clinical Respiratory Journal , vol. 4, no. 1, 1293386Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom
COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 14, no. 5, pp. 504-512Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
Clinical and Translational Allergy, vol. 6, 47Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
It is important to distinguish between HFrEF and HFpEF when interpreting these data: The Authors' reply
Heart, vol. 102, no. 23, pp. 1934Contributions to Journals: Letters- [ONLINE] DOI:
- [ONLINE]
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
Heart, vol. 102, no. 23, pp. 1909-1914Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project
Clinical and Translational Allergy, vol. 6, 41Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG
npj Primary Care Respiratory Medicine, vol. 26, 16069Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
npj Primary Care Respiratory Medicine, vol. 26, 16061Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up
Multidisciplinary respiratory medicine, vol. 11, 39Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]
A practical tool for primary care antimicrobial stewardship in children
The Lancet. Respiratory medicine, vol. 4, no. 11, pp. 850-852Contributions to Journals: Comments and Debates- [ONLINE] DOI:
- [OPEN ACCESS]
Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device
Respiratory Medicine, vol. 120, pp. 54-63Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations
Trials, vol. 17, 499Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort study
npj Primary Care Respiratory Medicine, vol. 26, 16076Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
COPD case finding: effective, but also cost-effective?
The Lancet. Respiratory medicine, vol. 4, no. 10, pp. e49Contributions to Journals: Letters- [ONLINE] DOI:
Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal
Applied Health Economics and Health Policy, vol. 14, no. 5, pp. 579-594Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
Respiratory Research, vol. 17, pp. 1-13Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]